🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Julie M. Jorns

Medical College of Wisconsin

ORCID: 0000-0002-7777-6670

Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy”.

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07038-3

N/A

0.545DataRank · unranked

10 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology

Annals of Surgical Oncology(2022)10.1245/s10434-022-12137-4

N/A

0DataRank · unranked

0 citations

Julie M. Jorns, Amanda L. Kong, Chandler S. Cortina, Enrique Ortega Martínez

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Modern Pathology(2023)10.1016/j.modpat.2022.100032

N/A

0DataRank · unranked

99 citations

Aileen I. Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll +17 more

Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1179025

N/A

0DataRank · unranked

12 citations

Tongtong Lu, Julie M. Jorns, Mollie Patton, Taly Gilat Schmidt, Tina Yen +3 more

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy

Research Square(2023)10.21203/rs.3.rs-2777910/v1

N/A

0DataRank · unranked

2 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Analysis of deep ultraviolet fluorescence images for intraoperative breast tumor margin assessment

PubMed(2023)10.1117/12.2649552

N/A

0DataRank · unranked

0 citations

Julie M. Jorns, Dong Hye Ye, Mollie Patton, Taly Gilat Schmidt, Tina Yen +2 more

Examining the false-negative rate of a negative axillary node ultrasound-guided core needle biopsy in breast cancer patients undergoing upfront surgery

The American Journal of Surgery(2024)10.1016/j.amjsurg.2024.116047

N/A

0DataRank · unranked

3 citations

Sarah Zeien, Kaleen Puccetti, Julie M. Jorns, Amanda L. Kong, Solomon Cherian +2 more

Deep Learning for Automated Detection of Breast Cancer in Deep Ultraviolet Fluorescence Images with Diffusion Probabilistic Model

PubMed(2024)10.1109/isbi56570.2024.10635349

N/A

0DataRank · unranked

10 citations

Tyrell To, Julie M. Jorns, Tina Yen, Bing Yu, Dong Hye Ye +1 more

Multi-institutional Assessment of Pathologist scoring HER2 Immunohistochemistry

Research Square(2022)10.21203/rs.3.rs-1763087/v1

N/A

0DataRank · unranked

7 citations

Aileen I. Fernandez, Han Gan, Serena Wong, Malini Harigopal, Mirna Podoll +17 more

Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer

Cancers(2025)10.3390/cancers17121921

N/A

0DataRank · unranked

1 citations

Steven Tau, Austin M. Sloop, Tianyuan Dai, Alyssa M. Roberts, Patricia C. Muskus +8 more